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ABSTRACT 
Objective: Angiotensin II is a potent vasoactive peptide that causes blood vessels to constrict, resulting in increased blood pressure. It acts through 
at least two types of receptors. The angiotensin II receptor type 1 gene (AGTR1) encodes the type 1 receptor (AT1). The AT1 receptor mediates the 
major cardiovascular effects of angiotensin II. A single nucleotide polymorphism (SNP) in the 3’-untranslated region of the AGTR1 gene (A1166C) 
has been linked in several studies with essential hypertension. A new analytical approach based on allele-specific polymerase chain reaction (AS-
PCR) was developed in this study to detect this SNP.  
Methods: Allele-specific primers were designed by using appropriate software to allow the PCR amplification only if the nucleotide at the 3’-end of 
the primer complements the base of the wild-type or variant-type DNA sample. The primers were then tested for uniqueness using the Basic Local 
Alignment Search Tool search engine. The developed method was tested on 21 samples. 
Results: The developed method accurately detected the genotype of the SNP. Our results were validated using the reference method for detecting 
A1166C SNP, PCR-restriction fragment length polymorphism (PCR-RFLP). The use of AS-PCR technique reduced both time and cost of the A1166C 
AGTR1 genotyping. Moreover, the AS-PCR test is more suitable as it reduces the false results due to incompletely digested PCR products, which can 
be a problem with PCR-RFLP technique.  
Conclusion: The use of this method will enable researchers to carry out genetic polymorphism studies for the association of A1166C SNP in AGTR1 
gene with essential hypertension and other heart diseases without the use of expensive instrumentation and reagents. 
Keywords: Essential hypertension, SNP, Angiotensin II type 1 receptor gene (AGTR1), Renin-angiotensin system, AS-PCR 
© 2016 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/) 
 
INTRODUCTION 
The renin–angiotensin system (RAS) or the renin–angiotensin–
aldosterone system (RAAS) is a hormone system that regulates 
blood pressure and water (fluid) balance. When renal blood flow is 
reduced, juxtaglomerular cells in the kidneys convert the prorenin 
already present in the blood into renin and secrete it directly into 
circulation. Plasma renin then carries out the conversion of 
angiotensinogen released by the liver to angiotensin I [1]. 
Angiotensin I is subsequently converted to angiotensin II by the 
enzyme angiotensin-converting enzyme. Angiotensin II is a potent 
vasoactive peptide that causes blood vessels to constrict, resulting in 
increased blood pressure. Angiotensin II also stimulates the 
secretion of the hormone aldosterone from the adrenal cortex [2]. 
Aldosterone causes the tubules of the kidneys to increase the 
reabsorption of sodium and water into the blood. This increases the 
volume of fluid in the body, which leads to elevated blood pressure 
[3]. Fig. 1 below illustrates the pathways of the RAS system. 
Angiotensin II acts through at least two types of receptors. The gene 
AGTR1 encodes the type 1 receptor AT1 which is a class of G protein-
coupled receptors [4]. AT1 is found in the heart, blood vessels, 
kidney, adrenal cortex, lung and brain [5]. The AT1 receptor 
mediates the major cardiovascular effects of angiotensin II. Effects 
include vasoconstriction, aldosterone synthesis, and secretion, 
increased vasopressin secretion, cardiac hypertrophy, augmentation 
of peripheral noradrenergic activity, vascular smooth muscle cells 
proliferation, and decreased renal blood flow, renal renin inhibition, 
and renal tubular sodium reuptake, modulation of central 
sympathetic nervous system activity, cardiac contractility, central 
osmoregulation and extracellular matrix formation [6]. 
A polymorphism in the 3’-untranslated region of the AGTR1 gene 
(A1166C) has been linked in several studies with essential 
hypertension. In wild-type A1166, a translational repression occurs, 
and the AT1 receptor is translated in normal levels. On the other 
side, with the variant-type C1166 translational repression does not 
happen and as a result, the AT1 receptor is translated with elevated 
levels which lead to the increase of the receptor function [7]. 
 
 
Fig. 1: Schematic illustration of the renin-angiotensin system (RAS) 
 
Allele-specific polymerase chain reaction (AS-PCR), also known as 
the amplification refractory mutation system (ARMS) or PCR 
amplification of specific alleles (PASA) is a PCR-based method which 
can be employed to detect a known SNP [8]. The concept of AS-PCR 
was initiated by Newton et al. [9], approximately six years after PCR 
was invented. In this approach, the specific primers are designed to 
permit amplification by DNA polymerase only if the nucleotide at the 
3’-end of the primer perfectly complements the base of the variant 
or wild-type sequences. 
International Journal of Pharmacy and Pharmaceutical Sciences 
ISSN- 0975-1491                  Vol 8, Issue 7, 2016 
Abajy et al. 




Fig. 2: Schematic illustration of the A1166C SNP in the AGTR1 gene 
 
After the PCR and electrophoresis, the patterns of specific PCR 
products allow the differentiation of the SNPs. Several approaches 
have been used to detect the presence of specific PCR product. Some 
are based on probe hybridization which requires specific labeled 
probes [10] and melting curve analysis [11] which requires nucleic 
acid stains. AS-PCR has been utilized widely in many areas of study 
such as pharmacogenetics [12], genetic disorders [13, 14], 
microbiology [15] and others. 
The AS-PCR approach in determining SNP is relatively cheaper than 
other methods. The crucial aspects in creating a working AS-PCR-
based genotyping system are primer design and optimizing PCR. 
Once the optimized protocol has been achieved, the execution of AS-
PCR is relatively simple, similar to the conventional PCR. 
The aim of this study was to develop, validate and utilize an AS-PCR 
method to determine the AGTR1 (A1166C) SNP genotype. 
MATERIALS AND METHODS 
DNA samples 
Subjects were recruited from the Cancer Research Center of 
Aleppo University, Aleppo, Syria. 5 ml of blood were collected 
from each subject. Genomic DNA was extracted from whole 
blood using the GF-1 Blood DNA Extraction Kit (Vivantis, 
Malaysia) according to the manufacturer’s instructions. DNA 
samples were stored at-20 °C until they were used. Samples 
were inspected for their SNP genotypes using both the reference 
PCR-RFLP method [16] and the developed AS-PCR. Results were 
compared and discussed in this paper. 
Sequence data 
Data for the AGTR1 gene sequence and the SNP region were 
retrieved from the Genebank of the NCBI website (National Center 
for Biotechnology Information). 
AS-PCR 
The genotyping method used to detect the selected SNP was 
developed using AS-PCR. Primers were designed with the aid of 
Primer designer software, version 2.0 and searched for uniqueness 
using the NCBI BLAST search engine [17]. The primers were 
designed to amplify a 448 bp DNA fragment of the AGTR1 gene 
(Genbank reference number NC_000003.11). The sequences of the 
primers are shown in table 1. 
 
Table 1: Sequence of primers for genotyping of the polymorphism of AGTR.1 gene 




The AS-PCR consists of two complementary reactions (two tubes) and utilizes 3 primers. The AGTR-rev primer is constant and complementary to 
the template in both reactions, while the forward primers differ at their 3' terminal residues and are specific to either the wild type (AGTR-W) or 
the variant type (AGTR-V). Only one of these forward primers is used per tube. 
 
PCR was carried out using a gradient thermocycler (TaKaRa, Japan). 
 
Fig. 3: A part of the AGTR1 gene sequence around the SNP site. The highlighted sequence shows the designed primers which are specific at 
their 3' site to the genotype of the SNP 
 
Each PCR reaction was carried out in two tubes, one containing 
the wild type forward primer and the other contained the 
variant type. The final volume of all PCR protocols was 25 μl 
contains: 1X ViBuffer A (500 mM KCl, 100 mM Tris-HCl "pH9.1 at 
20 °C" and 0.1% TritonTM X-100), 2 U of Taq DNA polymerase 
(Vivantis, Malaysia), 0.4 μM of each primer, 6 mM of MgCl 2, 0.2 
mM of dNTPs, and 25 ng of DNA. The PCR cycling was performed 
with an initial denaturation at 94 °C for 5 min, followed by 35 cycles 
of amplification; 94 °C for 30 sec, 53.2 °C for 30 sec and 72 °C for 60 
sec. The final extension was performed at 72 °C for 10 min. 
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Agarose gel electrophoresis 
Genomic DNA and PCR-Products were separated on 0.8% and 2% 
agarose gel respectively. Using 1X TEA buffer and applying field 
strength of 5 v. cm-1
To optimize a successful PCR protocol, we started from the reference 
PCR-RFLP protocol and developed it to be optimal for our designed 
primers. The most challenging problem we faced was to increase the 
PCR product to have a strong band on the agarose gel without the 
presence of unspecific PCR products. We used the PCR gradient 
technique to determine the optimal conditions for annealing 
temperature and Mg
. The DNA was stained with ethidium bromide 
and visualized using a video documentation system (Nise UV; 
Daihan Scientific Co., Korea). 
Validation and accuracy of method 
21 DNA samples were genotyped for AGTR1 A1166C SNP using the 
AS-PCR protocol developed in our research, and the method was 
validated by Restriction Fragment Length Polymorphism (PCR-
RFLP) strategy which is the reference method for detecting the 




concentration. Amplification and analysis of 
the SNP were performed successfully as showed in fig. 3. The 
presence of PCR bands with a size of 448 bp, which corresponds 
with the theoretical size (Genbank reference number 
NC_000003.11), indicated the genotype of the samples. For each 
DNA sample two PCR reactions were performed; the first with the 
AGTR-W primer and the second with the AGTR-V primer. The SNP 
genotype can be determined according to the number of the resulted 
amplicons as explained in table 2. The genotypes for the samples 
were 14 for AA and 7 for AC. The results that were obtained from the 
developed AS-PCR method were all consistent with genotype data 
obtained using the reference PCR-RFLP technique. 
 
Fig. 4: The electrophoresis profiles for some of the successful 
amplifications. Samples 5, 6, 7, 8, 9 and 33 have the 
homozygous genotype AA, while samples 20, 23, 26, 27, 28 and 
32 has the heterozygous genotype AC. The ladder we used is 
GeneRuler 1 kb DNA Ladder, Fermentas
 
Table 2: The size of amplicons and the genotypes for A1166C SNP in the AGTR1 gene 
Wild type tube Variant type tube Genotype 
448 bp amplicon No band AA 
448 bp amplicon 448 bp amplicon AC 
No band 448 bp amplicon CC 
 
DISCUSSION 
As mentioned, AS-PCR consists of two complementary reactions 
(two tubes) and utilizes 3 primers. Therefore, three primers were 
designed (AGTR-W, AGTR-V and AGTR-rev). The forward primers, 
AGTR-W and AGTR-V, are allele-specific primers as the nucleotide at 
the 3’-end of each allele-specific primer perfectly matches the SNP 
site (AGTR-W primer is complementary to the wild-type allele, while 
AGTR-V primer is complementary to variant type allele); only one of 
these primers is used per tube. The reverse primer AGTR-rev is 
constant and complementary to the template in both reactions. If the 
sample is a homozygous variant or homozygous wild type, 
amplification will only take place in one of the two tubes. If the 
sample is heterozygous, amplification will be seen in both tubes. 
The PCR was optimized by adjusting the concentration of the 
primers, MgCl2 and annealing temperatures. The optimum 
annealing temperature and MgCl2
There are several methods that can be used to detect SNPs, such as 
PCR-restriction fragment length polymorphism (PCR-RFLP), high 
resolution melting (HRM), pyrosequencing and probe hybridization-
based techniques. PCR-RFLP has some disadvantages such as the 
necessity of an incubation period for enzymatic digestion by 
restriction endonuclease to separate the restriction fragments, false 
results due to incompletely digested PCR products and the cost of 
the restriction enzymes [18]. The other methods mentioned above 
are faster and easier to determine SNPs [19, 20] but these methods 
are expensive because they require the use of high technology 
instrumentations and costly reagents. 
 concentration were determined 
using a gradient PCR. Under optimized PCR components and 
conditions, the patterns of PCR bands that form after agarose gel 
electrophoresis enable an effective characterization of the SNP 
genotype. The inclusion of a negative external control, a reaction 
containing all PCR components except the DNA sample, was to 
confirm the absence of contamination and false positive results. 
The AS-PCR method developed in this study only requires basic 
equipment such as a conventional thermal cycler and a gel 
documentation system which are available in most genetic 
laboratories. It is cost-effective as it does not use fluorescent nucleic 
acid stains or hybridization probes. This makes it suitable to be used in 
studies where lack of funding, equipment or expertise may be a factor. 
CONCLUSION 
The use of this method will, therefore, enable researchers to carry 
out genetic polymorphism studies for the association of A1166C 
SNP in AGTR1 gene with essential hypertension and other heart 
diseases without the use of expensive instrumentation and 
reagents. 
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